Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Blind Randomized Clinical Trial, With Active Controls, to Evaluate the Immunogenicity and Safety of the Quadrivalent Influenza Vaccine (Split Virion, Inactivated) From Instituto Butantan, in Infants and Children Aged 6 to 35 Months.

NCT05779020 is registered in ClinicalTrials.gov with Butantan Institute as lead sponsor.

NCT NCT05779020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05779020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Blind Randomized Clinical Trial, With Active Controls, to Evaluate the Immunogenicity and Safety of the Quadrivalent Influenza Vaccine (Split Virion, Inactivated) From Instituto Butantan, in Infants and Children Aged 6 to 35 Months.
Lead sponsor
Butantan Institute
Phase
Phase 3
Overall status
Completed
Start date
April 25, 2023
Completion date
August 2, 2025
Enrollment
1,373 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, human